The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
THC · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | THC | TDY | CODA | USNA |
|---|---|---|---|---|
| Moat Score (0–100) | 63 | 64 (highest) | 64 (highest) | 63 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 75 | 90 (highest) | 48 | 5 |
| Pricing power | — | 65 | 98 | 100 (highest) |
| Returns on capital | 49 | 25 | 63 | 97 (highest) |
| Balance-sheet safety | 28 | 79 | 100 (highest) | 73 |
| Capital allocation | 100 (highest) | 60 | 9 | 40 |
| 25% above value if growth stopped today | 146% above value if growth stopped today | 144% above value if growth stopped today | 60% below value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $23.2B | $28.6B | $112M | $284M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |